Penicillamine in rheumatoid disease
Thrift, E.G.; Lewis, B.
Australian Family Physician 12(12): 870-871
1983
ISSN/ISBN: 0300-8495 PMID: 6670953 Document Number: 204248
Penicillamine is a slow acting oral antirheumatic drug and a chelating agent. Although it is derived from penicillin, allergy to that is not an absolute contraindication to the use of penicillamine.
Document emailed within 1 workday
Related Documents
Brenner, S.; Caspi, D.; Tchetchik, R.; Krakowski, A.; Yaron, M. 1983: Pemphigus folliaceous following D-penicillamine in rheumatoid arthritis Harefuah 104(3): 94-96Seideman, P.; Lindström, B. 1989: Pharmacokinetic interactions of penicillamine in rheumatoid arthritis Journal of Rheumatology 16(4): 473-474
Waskönig, F.W.; Meyer, W. 1973: The basal therapy of rheumatoid arthritis with d-penicillamine Münchener Medizinische Wochenschrift 115(45): 2047-2050
Matthey, F.; Perrett, D.; Greenwood, R.N.; Baker, L.R. 1986: The use of D-penicillamine in patients with rheumatoid arthritis undergoing hemodialysis Clinical Nephrology 25(5): 268-271
Huskisson, E.C. 1981: The side effects of penicillamine therapy in rheumatoid arthritis Journal of Rheumatology. Suppl 7: 146-148
Siame, J.L.; Cocheteux, P.; Delcambre, B. 1981: Severe bronchiolitis in rheumatoid arthritis treated with D-penicillamine Revue du Rhumatisme et des Maladies Osteo-Articulaires 48(7-9): 605-606
Christoph, R.; Genth, E.; Grussendorf, E.I.; Hartl, P.W. 1978: Pemphigus syndrome in D-penicillamine treated rheumatoid arthritis Die Medizinische Welt 29(45): 1761-1763
Miyamoto, S.; Inoue, T. 1992: Gold compounds and D-penicillamine for therapy of rheumatoid arthritis Nihon Rinsho. Japanese Journal of Clinical Medicine 50(3): 515-520
Gordon, R.A.; Burnside, J.W. 1977: D-Penicillamine-induced myasthenia gravis in rheumatoid arthritis Annals of Internal Medicine 87(5): 578-579
Huskisson, E.C.; Berry, H. 1974: Some immunological changes in rheumatoid arthritis among patients receiving penicillamine and gold Postgraduate Medical Journal 50(Suppl 2): 59-61
Renier, J.C.; Bontoux-Carre, E.; Racineux, J.L. 1986: 3 cases of obliterating bronchiolitis during treatment of rheumatoid polyarthritis with D-penicillamine Revue du Rhumatisme et des Maladies Osteo-Articulaires 53(1): 25-26
Kutsuna, T.; Maeda, K.; Okamoto, T. 1986: Long-term results of D-penicillamine treatment in rheumatoid arthritis Ryumachi 26(4): 270-277
Partsch, G.; Tausch, G.; Neuwirth, E.; Neumüller, J. 1983: The effect of D-penicillamine on plasma amino acids in rheumatoid arthritis Zeitschrift für Rheumatologie 42(3): 126-129
Ongerboer de Visser, B.W.; van Soesbergen, R.M. 1978: Myasthenia gravis as a complication of D-penicillamine treatment in rheumatoid arthritis Nederlands Tijdschrift Voor Geneeskunde 122(52): 2055-2058
Speerstra, F.; Reekers, P.; van de Putte, L.B.; Vandenbroucke, J.P.; Rasker, J.J.; de Rooij, D.J. 1983: HLA-DR antigens and proteinuria induced by aurothioglucose and D-penicillamine in patients with rheumatoid arthritis Journal of Rheumatology 10(6): 948-953
Nezić-Ivković, J.; Dürrigl, T. 1978: A trial of comparative effects of gold salts and D-penicillamine in rheumatoid arthritis Reumatizam 25(3): 75-78
Gigante, D.; Teodori, S.; Crispo, M. 1983: Basic therapy of rheumatoid arthritis with D-penicillamine. Personal contribution and critical observations Fortschritte der Medizin 101(13): 613-618
Shiokawa, Y.; Horiuchi, T.; Honma, M.; Kageyama, T.; Okada, T. 1977: Clinical evaluation of D-penicillamine for the treatment of rheumatoid arthritis by a double blind test Ryumachi 17(2): 205-210
Moens, H.J.; Ament, B.J.; Feltkamp, B.W.; van der Korst, J.K. 1987: Longterm followup of treatment with D-penicillamine for rheumatoid arthritis: effectivity and toxicity in relation to HLA antigens Journal of Rheumatology 14(6): 1115-1119
Dawes, P.T.; Sheeran, T.P.; Fowler, P.D.; Shadforth, M.F. 1987: Improving the response to gold or D-penicillamine by addition of sulphasalazine. a pilot study in 25 patients with rheumatoid arthritis Clinical and Experimental Rheumatology 5(2): 151-153